Lexicon Pharmaceuticals Inc (LXRX)

NASDAQ
3.060
-0.080(-2.55%)
After Hours
3.090
+0.030(+0.98%)
- Real-time Data
  • Volume:
    324,667
  • Bid/Ask:
    3.100/3.600
  • Day's Range:
    3.040 - 3.250

LXRX Comments

What is your sentiment on Lexicon Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

All Comments

(152)
  • how your bullish?
    0
    • Picked up more shares this morning!
      0
  • believe me this stock will be 15-18$ on partnership news... that should happen in max 2 weeks so you better buy guys.
    0
    • Today I think it is the time to buy before the next bullish :)
      0
      • Picked up more today! Holding 6740 shares!
        0
        • Increased my position!
          0
      • let's hit 9 today
        2
        • Been holding since $1.90.
          0
          • I've been here for $ 3.80 This year $ 20 + Read the news who's the director. 93% of the shares are owned by the bosses.
            0
            • Tomorrow, to the moon ? :D
              0
              • Maybe we go to 9$ today :D
                2
                • Go man, go!!
                  0
                  • buy while you can, another leg up is on its way
                    1
                    • can't wait......🧐
                      0
                  • bye bye miss american pie..
                    0
                    • Seems to be holding quite good, wonder if it dips down a bit to 7 or so, I'd buy.
                      0
                      • Instant 6% gain! Time to find a *****😋
                        0
                        • big time!
                          0
                          • The pre-market is +4.66%. That seems good :)
                            0
                            • Not selling before 15-16, this is holding just fine
                              0
                              • Lexicon Pharmaceuticals Inc : Citigroup raises price target to $13 from $6.
                                0
                                • Shorts are due to cover today.
                                  0
                                  • As it happened in most of the big jumps, it always goes down like this. So it needed to be sold yesterday at around 9 for max profit.
                                    0
                                    • Exactly ! It is "normal' but I think in the end and the month or in the beginning of February it can go to 10$.
                                      0
                                    • Amaury Delard Agree on it. it should recover back in some time.
                                      0
                                    • it'll go way past 10. This was real news yesterday. Bad day on the market as a whole.
                                      0
                                  • just volatility?  think it wont go down
                                    0
                                    • Guys, in your opinion, to the moon or down? I have bought for 8.23
                                      0
                                      • That was third rebuy, i was long from 3$
                                        0
                                      • Ollár ZoltánOk .... thanks u haha
                                        0
                                      • You will make money even biught at 8.23. Need more knowledge to make more.
                                        0
                                    • https://thefly.com/n.php?id=3227931
                                      1
                                      • Lexicon price target raised to $13 from $6 at Citi Citi analyst Yigal Nochomovitz raised the firm's price target on Lexicon to $13 from $6 and keeps a Buy rating on the shares, following the company's disclosure that the FDA will accept the SCORED and SOLOIST trials as the basis of an NDA filing for sotagliflozin in T2D patients with heart failure. The analyst sees this "removing a key regulatory overhang and clearing a path for striking a partnership" for Lexicon. Nochomovitz increased his likelihood of success for the drug in T2D heart failure patients to 90% from 75% following "FDA feedback that SCORED and SOLOIST are sufficient to file sota for regulatory approval." Read more at:  https://thefly.com/n.php?id=3227931
                                        0
                                        • its gonna do alot better than 8. no hype just positive results
                                          0
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.